These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17651933)

  • 1. Nanostructured lipid carrier (NLC) based gel of celecoxib.
    Joshi M; Patravale V
    Int J Pharm; 2008 Jan; 346(1-2):124-32. PubMed ID: 17651933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib.
    Joshi M; Patravale V
    Drug Dev Ind Pharm; 2006 Sep; 32(8):911-8. PubMed ID: 16954103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation.
    Fetih G; Fathalla D; El-Badry M
    Drug Dev Res; 2014 Jun; 75(4):257-66. PubMed ID: 24939834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
    Nagaich U; Gulati N
    Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
    Patel AR; Chougule MB; I T; Patlolla R; Wang G; Singh M
    Pharm Res; 2013 May; 30(5):1435-46. PubMed ID: 23361589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment.
    Shen CY; Dai L; Shen BD; Zhou X; Bai JX; Xu H; Lv QY; Han J; Yuan HL
    Chin J Nat Med; 2015 Jun; 13(6):454-60. PubMed ID: 26073342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation.
    Patel D; Dasgupta S; Dey S; Ramani YR; Ray S; Mazumder B
    Sci Pharm; 2012; 80(3):749-64. PubMed ID: 23008819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
    Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
    Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.